Year: 2020

Vacancy: Scientist Immunology

Due to exciting expansion across the company, with offices in the UK (headquarters), USA, Italy and Australia, Vaccitech is now recruiting for a Immunology Scientist. This is a full time office and laboratory-based role in the UK (37.5 hours per week). Please see the...

Vacancy: Research Associate

Due to exciting expansion across the company, with offices in the UK (headquarters), USA, Italy and Australia, Vaccitech is now recruiting for a Research Associate. The role is office and laboratory-based in the UK on a full time basis (37.5 hours per week). Please...

Oxford University breakthrough on global COVID-19 vaccine

Oxford, UK - Vaccitech’s scientific founders at University of Oxford announce positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil. Phase 3 interim analysis including 131 Covid-19 cases indicates that the vaccine is...

Apprentice Laboratory Technician

Vaccitech is looking to employ an Apprentice Laboratory Technician to provide technical support for the day-to-day smooth operation of our vaccine research laboratory, as well completing training to become a fully qualified laboratory technician. This position will...

Vacancies: 2 x Clinical Study Managers

Due to exciting expansion across the company, with offices in the UK (headquarters), USA, Italy and Australia, Vaccitech is now recruiting for two Clinical Study Managers, which are office-based roles in the UK on a full time basis (37.5 hours per week). Please see...

Vaccitech expands management team with hires including CMO and CFO

Oxford, UK – Vaccitech Ltd, a clinical-stage biopharmaceutical company developing T cell vaccines and immunotherapies designed to treat and prevent infectious disease and cancer, today announces the appointment of three new senior leaders across its clinical,...

Vaccitech receives government grant for COVID-19 vaccine research

Oxford, UK - Vaccitech Ltd, a clinical-stage biopharmaceutical company developing immunotherapies to treat and prevent infectious diseases and cancer, announces today that it has received a non-dilutive Government grant to support research with its next-generation...